Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - propranolol hydrochloride - film-coated tablet - propranolol

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - propranolol hydrochloride - film-coated tablet - propranolol

New Zealand - English - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - propranolol hydrochloride 10mg - tablet - 10 mg - active: propranolol hydrochloride 10mg excipient: sunset yellow fcf aluminium lake cl15985 lactose monohydrate magnesium stearate maize starch povidone quinoline yellow sodium starch glycolate - management of angina pectoris.

New Zealand - English - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - propranolol hydrochloride 40mg - tablet - 40 mg - active: propranolol hydrochloride 40mg excipient: sunset yellow fcf aluminium lake cl15985 brilliant blue fcf aluminium lake cl42090 lactose monohydrate magnesium stearate maize starch povidone quinoline yellow sodium starch glycolate - management of angina pectoris.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: povidone; sodium starch glycollate; lactose monohydrate; quinoline yellow; magnesium stearate; maize starch; sunset yellow fcf aluminium lake; brilliant blue fcf aluminium lake - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; povidone; sunset yellow fcf aluminium lake; magnesium stearate; quinoline yellow; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 10 mg - propranolol hydrochloride tablets are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. prop

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 10 mg - propranolol hydrochloride tablets are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. prop

United States - English - NLM (National Library of Medicine)

rouses point pharm - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg - propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules are not indicated in the management of hypertensive emergencies. propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. propranolol hydrochloride extended-release capsules improve nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block;

United States - English - NLM (National Library of Medicine)

avkare - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg - propranolol hydrochloride extended-release capsules, usp, are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride extended-release capsules, usp, are not indicated in the management of hypertensive emergencies. propranolol hydrochloride extended-release capsules, usp, are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride extended-release capsules, usp, are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. propranolol hydrochloride extended-release capsules, usp, improve nyha functional class in symptomatic patients with hypertrophic subaortic stenosis. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3) bronchial asthma; and 4) in patients with known hypersensitivity to propranolol hydrochloride.